News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Andrius Žučenka: Stop by at our EHA2024 poster on relapsed/refractory AML
Photo of Andrius Žučenka from vjhemonc.com
Jun 16, 2024, 02:39

Andrius Žučenka: Stop by at our EHA2024 poster on relapsed/refractory AML

Andrius Žučenka, Head of The Department of Specialized Care For Immunocompromised Patients at VUL Santaros Klinikos, shared a post on X:

“Please stop by at our EHA2024 poster P1325 with the results of the non-intensive, targeted therapy-based preconditioning regimens followed by standard conditioning and alloSCT in relapsed/refractory AML/HR-MDS patients with active disease (including TP53m/post-Ven).”

Andrius Žučenka: Stop by at our EHA2024 poster on relapsed/refractory AML

Source: Andrius Žučenka/X

active disease alloSCT Andrius Žučenka cancer EHA2024 HR-MDS OncoDaily Oncology P1325 post-Ven preconditioning regimens R/R AML standard conditioning targeted therapy TP53m
Special Coverage
Blog
Jul 10, 2025, 06:53
Iris Valtingojer: Announcing Sanofi's 4th Annual Childhood Cancer Symposium
Oncolibrary
Jul 10, 2025, 05:57
Press Release: Amgen's Bemarituzumab Shows Promise in Advanced Gastric Cancer
Drugs
Jul 10, 2025, 04:47
Taletrectinib (Ibtrozi) 2025 Updates: Uses in Cancer, Side effects, Dosage, Expectations and more
Oncolibrary
Jul 10, 2025, 04:47
Hormonal Therapy in Cancer: Mechanisms, Resistance and Clinical Applications in Breast and Prostate Cancer
Drugs
Jul 10, 2025, 01:19
Cisplatin in Cancer Treatment: Mechanism, Resistance, Toxicity, and Future Directions
Blog
Jul 9, 2025, 23:49
Sami Mansfield: Jumpstart July - Education plus Empowerment for Menopause After Cancer 
Blog
Jul 9, 2025, 23:47
Time to Renew Your ESO College Membership for 2026
Blog
Jul 9, 2025, 23:31
Few Days Left to Join Webinar on Nutrition’s Role in Cancer Care - SPCC
Blog
Jul 9, 2025, 23:14
New MSS colorectal cancer data presented at ESMOGI25 - Agenus
Insight
Jul 9, 2025, 23:06
Steven Rosenberg: The beginning of a new way to use immunotherapy
Blog
Jul 9, 2025, 22:41
Mariam Mailian: Feeling grateful after attending the ESMO GI Congress 2025
Blog
Jul 9, 2025, 22:10
Roland Busch: The busier the schedule, the more important the workout and discipline becomes